MiRagen Therapeutics Receives $8,499,962 New Financing Round

  • Feed Type
  • Date
    2/18/2015
  • Company Name
    MiRagen Therapeutics
  • Mailing Address
    6200 Lookout Rd Boulder, CO 80301 USA
  • Company Description
    Miragen was founded in 2007 to exploit recent discoveries showing that specific perturbations in microRNA expression are correlated with various forms of cardiovascular disease.
  • Website
    http://www.miragentherapeutics.com
  • Transaction Type
    Debt
  • Transaction Amount
    $8,499,962
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy